CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $981,869 | -10.0% | 106,841 | +0.0% | 0.01% | -16.7% |
| Q4 2022 | $1,090,663 | -30.4% | 106,823 | +0.4% | 0.01% | -25.0% |
| Q3 2022 | $1,566,000 | +37.1% | 106,391 | 0.0% | 0.01% | +60.0% |
| Q2 2022 | $1,142,000 | -2.4% | 106,391 | -2.0% | 0.01% | +25.0% |
| Q1 2022 | $1,170,000 | -34.3% | 108,514 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $1,780,000 | -26.4% | 109,088 | -3.4% | 0.00% | -33.3% |
| Q3 2021 | $2,419,000 | – | 112,980 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |